NEW YORK (360Dx) – Prognos, a company applying artificial intelligence to clinical lab diagnostics, announced it has completed a $20.5 million Series C round of financing, bringing the company's total funding to $42 million.

Investors in the recent financing round include Cigna; GIS Strategic Ventures, which is the venture capital arm of the Guardian Life Insurance Company; Hermed; Hikma Ventures; Maywic; Merck Global Health Innovation Fund; and Safeguard Scientifics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.